| Literature DB >> 28832798 |
Serhat Huseyin1, Orkut Guclu1, Volkan Yüksel1, Gulen Sezer Alptekin Erkul1, Nuray Can2, Fatma Nesrin Turan3, Suat Canbaz1.
Abstract
OBJECTIVE: : Ischemia-reperfusion injury after acute ischemia treatment is a serious condition with high mortality and morbidity. Ischemia-reperfusion injury may result in organ failure particularly in kidney, lung, liver, and heart. In our study, we investigated the effects of papaverine and vitamin C on ischemia-reperfusion injury developed in the rat liver after occlusion-reperfusion of rat aorta.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28832798 PMCID: PMC5570388 DOI: 10.21470/1678-9741-2016-0081
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Suzuki scoring scale.
| Score | Congestion | Cytoplasmic vacuolization | Parenchymal necrosis |
|---|---|---|---|
| 0 | No | No | No |
| 1 | Minimal | Minimal | Single-cell necrosis |
| 2 | Mild | Mild | < 30% |
| 3 | Moderate | Moderate | < 60% |
| 4 | Severe | Severe | > 60% |
Fig. 1A) Group 1 subject 1, score 0: regular hepatic histology. B) Group 1 subject 8, score 1: sinusoidal congestion findings. C) Group 2 subject 6, score 4: marked congestion, extensive cytoplasmic vacuolization, focal cellular necrosis. D) Group 4 subject 5, score 2: sinusoidal congestion, mild level of cytoplasmic vacuolization. E) Group 4 subject 6. score 3: moderate level of congestion and cytoplasmic vacuolization.
Histopathological scores by groups.
| Group | Median | Minimum | Maximum |
|---|---|---|---|
| Control (n=8) | 10.000 | 0 | 1.00 |
| Ischemia-reperfusion (n=8) | 20.000 | 1.00 | 4.00 |
| I-R +Vit C (n=8) | 10.000 | 0 | 2.00 |
| I-R+ Papaverine (n=8) | 10.000 | 0 | 3.00 |
Fig. 2Histopathological scores by groups.
| Abbreviations, acronyms & symbols | |
|---|---|
| I-R | = Ischemia-reperfusion |
| Papaverine HCL | = Papaverine hydrochloride |
| Authors' roles & responsibilities | |
|---|---|
| SH | Conception and design study; conduct of procedures and/or experiments; writing of the manuscript or review of its content; final manuscript approval |
| OG | Analysis and/or data interpretation; final manuscript approval |
| VY | Manuscript redaction or critical review of its content; final manuscript approval |
| GSAE | Analysis and/or data interpretation; final manuscript approval |
| NC | Pathological examination; final manuscript approval |
| FNT | Statistical analysis; final manuscript approval |
| SC | Critical review of its content; final manuscript approval |